Encompass Health Corporation (EHC) is currently Overvalued by 62.58%

Instant valuation answer

Encompass Health Corporation (EHC) appears overvalued by approximately 62.58% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

  • Downside (live) 62.58% (from live valuation API)
  • Confidence (live) 8.5/10 (High conviction overvalued)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$106.99

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Why is Encompass Health Corporation overvalued or undervalued?

Based on intrinsic value, Encompass Health Corporation (EHC) looks priced with a margin of safety relative to a cash-flow-based fair value that blends growth, reinvestment needs, and a risk-adjusted discount rate.

Compared to historical valuation, today’s multiple sits under the range implied by the company’s own five-year average—suggesting the market is more cautious than its own past pricing of similar fundamentals.

Market expectations embedded in the price imply a modest bar for execution: revenue cadence, margin stability, and capital returns would need to hold up to justify a sustained discount versus fair value.

Key metrics

P/E ratio
32.6x
Revenue growth (TTM y/y)
17%
Profit margin
33.3%
Fair value (model)
Unlock

Frequently asked questions — EHC

Is EHC overvalued right now?

Based on our 2026 models, Encompass Health Corporation (EHC) appears overvalued at $106.99 with roughly 62.6% downside versus fair value. Confirm with valuation ratios and financials before acting.

What is Encompass Health Corporation's intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether EHC trades above or below fair value. At $106.99, Encompass Health Corporation currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Encompass Health Corporation's intrinsic value calculated?

Tickerplace calculates EHC's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is EHC undervalued right now?

A stock is undervalued when price sits below a supportable fair value range. Check whether EHC's gap aligns with fundamentals using the ratios and financial links on this page.

Peers for EHC: open their overvalued / undervalued view.